IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CHIESA, GIULIA MARIA CAROLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.621
AS - Asia 11.352
NA - Nord America 10.404
SA - Sud America 1.085
AF - Africa 196
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 5
Totale 36.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.091
GB - Regno Unito 3.630
CN - Cina 3.533
SG - Singapore 3.392
IT - Italia 2.812
DE - Germania 2.794
HK - Hong Kong 1.070
SE - Svezia 1.009
RU - Federazione Russa 973
BR - Brasile 824
VN - Vietnam 794
BD - Bangladesh 655
FR - Francia 575
IN - India 494
TR - Turchia 384
IE - Irlanda 357
NL - Olanda 348
KR - Corea 335
FI - Finlandia 316
UA - Ucraina 231
ID - Indonesia 179
CA - Canada 172
JP - Giappone 151
EU - Europa 123
DK - Danimarca 113
CO - Colombia 81
PL - Polonia 80
GR - Grecia 71
AR - Argentina 69
MX - Messico 67
ES - Italia 63
IQ - Iraq 54
PH - Filippine 54
CI - Costa d'Avorio 53
CH - Svizzera 43
AU - Australia 38
AT - Austria 37
BE - Belgio 36
PK - Pakistan 33
EC - Ecuador 32
TW - Taiwan 32
ZA - Sudafrica 25
MA - Marocco 24
SA - Arabia Saudita 24
UZ - Uzbekistan 24
CL - Cile 23
VE - Venezuela 22
AE - Emirati Arabi Uniti 18
MY - Malesia 18
EG - Egitto 17
JO - Giordania 17
TN - Tunisia 16
PT - Portogallo 15
RO - Romania 15
RS - Serbia 15
SV - El Salvador 15
KE - Kenya 13
CZ - Repubblica Ceca 12
LT - Lituania 12
PE - Perù 12
BA - Bosnia-Erzegovina 11
IR - Iran 11
BO - Bolivia 10
CR - Costa Rica 10
NP - Nepal 10
DZ - Algeria 9
JM - Giamaica 9
SN - Senegal 9
HU - Ungheria 8
NO - Norvegia 8
OM - Oman 8
AL - Albania 7
BB - Barbados 7
KG - Kirghizistan 7
KZ - Kazakistan 7
PY - Paraguay 7
SC - Seychelles 7
TH - Thailandia 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 5
HN - Honduras 5
LU - Lussemburgo 5
PR - Porto Rico 5
PS - Palestinian Territory 5
BG - Bulgaria 4
BY - Bielorussia 4
ET - Etiopia 4
GH - Ghana 4
GT - Guatemala 4
HR - Croazia 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
IL - Israele 3
LB - Libano 3
PA - Panama 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
Totale 36.773
Salva come PNG Salva come JPEG
Città #
Southend 3.375
Singapore 1.992
Hanover 1.258
Ashburn 1.057
Hong Kong 978
Milan 869
San Jose 698
Chandler 691
Beijing 627
Seattle 516
Princeton 463
Frankfurt am Main 457
Council Bluffs 419
Dallas 393
Santa Clara 385
Dublin 348
Wilmington 341
Fairfield 322
Los Angeles 304
Ann Arbor 252
Ho Chi Minh City 210
Lauterbourg 204
Houston 201
Nanjing 195
New York 189
Bengaluru 185
Guangzhou 173
Hanoi 173
Dearborn 171
Grafing 164
Boardman 163
Shanghai 162
Redmond 161
Woodbridge 152
Buffalo 151
Rome 140
Helsinki 134
Des Moines 129
Moscow 127
Jakarta 120
Hefei 117
Cambridge 115
Mountain View 108
Jacksonville 102
Sakarya 102
Jinan 99
Tianjin 89
Munich 87
Changsha 80
Shenyang 80
Redwood City 77
Seoul 72
Athens 70
Cangzhou 70
Tokyo 69
Columbus 68
Somerville 67
Eitensheim 64
São Paulo 62
Serra 58
Andover 56
Phoenix 56
Turin 56
Hangzhou 54
Abidjan 53
The Dalles 53
Berlin 52
Dong Ket 52
Bogotá 50
Warsaw 50
Bühl 49
Toronto 49
Chicago 48
Hebei 46
Nanchang 46
Roxbury 46
San Diego 42
Da Nang 41
Shenzhen 41
Fuzhou 40
Hamburg 39
Florence 38
Haiphong 38
Istanbul 38
Zhengzhou 38
Kent 36
Naples 36
Bologna 34
Amsterdam 33
Brussels 32
Nuremberg 31
Washington 31
Rio de Janeiro 30
Padova 29
Atlanta 28
Turku 28
Ningbo 26
Quanzhou 25
Mumbai 24
Orem 24
Totale 22.323
Salva come PNG Salva come JPEG
Nome #
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 961
Effetti dell’elevato intake di colina dietetica sul metaboloma plasmatico, lo sviluppo di aterosclerosi e la composizione del microbiota intestinale in topi EKO 520
Lipid phosphate phosphatase 3 in vascular pathophysiology 514
Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effects 483
Effetto della Colina Dietetica sul Metabolismo Lipidico e lo Sviluppo di Aterosclerosi in Modelli Murini con Deficit o Sovraespressione di Apolipoproteina A-I 480
Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation 432
Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein E knockout mice by the blood-pool contrast agent B22956/1 420
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure 414
High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology : A structural and ultrastructural study 393
Interazione tra gli acidi biliari e il microbiota intestinale: implicazioni fisiopatologiche = Reciprocal interactions between bile acids and intestinal microbiota: pathophysiological implications 389
Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids 384
Il trattamento con topiramato protegge i topi APOE-KO dall’insorgenza di danno renale senza modificare i livelli dei lipidi plasmatici 356
Acute effect of Tetranectin-ApoA-I infusion on atherosclerosis progression/regression in hypercholesterolemic rabbits 349
Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model 339
Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells 334
Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats 329
Aortic gene expression profiles show how ApoA-I levels modulate inflammation, lysosomal activity, and sphingolipid metabolism in murine atherosclerosis 315
A single infusion of trimeric apoA-I in hypercholesterolemic rabbits stabilizes atherosclerotic plaques and increases plasma cholesterol efflux capacity 298
Cholesterol accumulation and inflammation in skin and skin-draining lymph nodes in ApoE-KO mice lacking murine ApoA-I 297
An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasma Cholesterol-Lowering Activity in apoE(-/-) Mice 294
Liver-specific deletion of the PPAP2B gene worsens atherosclerosis in apoE-/- mice 282
L-homoarginine administration reduces neointimal hyperplasia in balloon-injured rat carotids 281
Fenretinide treatment accelerates atherosclerosis development in apolipoprotein e-deficient mice in spite of beneficial metabolic effects 276
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic Rabbits 272
Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion 270
Beta2-adrenergic activity modulates vascular tone regulation in lecithin : cholesterol acyltransferase knockout mice 270
Homoarginine administration reduces neointimal hyperplasia in a rat model of carotid artery balloon injury 270
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia 256
Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE -/- mice 255
A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in apoE-deficient mice 254
Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate 251
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations 240
High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells 235
Cholesterol-lowering effect of dietary Lupinus angustifolius proteins in adult rats through regulation of genes involved in cholesterol homeostasis 233
Fenretinide treatment in apoE-KO mice severely alters erythrocyte turnover and causes a dramatic increase of circulating leukocytes resulting in a worsened atherosclerosis development 233
The impact of lecithin: cholesterolacyltransferase on endothelial function: study on a genetically modified model 232
reString: an open-source Python software to perform automatic functional enrichment retrieval, results aggregation and data visualization 232
Apolipoprotein A-I and the molecular variant apoA-I Milano : evaluation of the antiatherogenic effects in a knock-in mouse model 222
liputils: a python module to manage individual fatty acid moieties from complex lipids 215
Nutraceuticals and bioactive components from fish for dyslipidemia and cardiovascular risk reduction 210
Il trattamento con fenretinide peggiora l’aterosclerosi nonostante effetti metabolici favorevoli 210
Evaluation of a soft atherosclerotic lesion in the rabbit aorta by an invasive IVUS method vs an non invasive MRI technology 209
Fat-shaped microbiota affects lipid metabolism, liver steatosis and intestinal homeostasis in mice fed a low-protein diet 209
Dysregulated expression of ankyrin repeat domain 1 in the developing myocardium causes anomalous venous return and morphogenetic defects by impairing cardiac remodelling 202
Rupatadine treatment is associated to atherosclerosis worsening and altered T lymphocyte recruitment 201
Hypocholesterolemic effect of the combination between vegetable proteins and fibres: impact on genes regulating cholesterol homeostasis 200
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL 199
The gut microbiota affects host pathophysiology as an endocrine organ : a focus on cardiovascular disease 196
A simple method for the characterization and quantification of soy isoflavone metabolites in the serum of MMTV-Neu mice using high-performance liquid chromatography/electrospray ionization mass spectrometry with multiple reaction monitoring 194
Effect of lupin proteins on lipid-lipoprotein metabolism: in vitro and in vivo studies 193
Effect of diet and genotype on the miRNome of mice with altered lipoprotein metabolism 192
Effect of Diets on Plasma and Aorta Lipidome: A Study in the apoE Knockout Mouse Model. 191
Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels 191
Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein Diet 191
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return 189
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a) 189
Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I-Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques - In vivo assessment by intravascular ultrasound and magnetic resonance imaging 184
Bioactive components from Antartic krill exert anti-atherosclerotic activity in apoe-deficient mice 183
ApoE-deficient mice and fenritinide: a structural study of the skin 183
Effect of Dietary Components from Antarctic Krill on Atherosclerosis in apoE-Deficient Mice 183
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease 182
ApoA-I deletion in apoE-KO mice promotes massive cholesterol accumulation and inflammation in skin and skin-draining lymph nodes 179
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant 178
Soy proteins reduce progression of a focal lesion and lipoprotein oxidiability in rabbits fed a cholesterol-rich diet 178
Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA 177
A transgenic mouse model for the detection of cellular stress induced by toxic inorganic compounds 176
ApoA-I deficiency in apoe-ko mice severely alters lymph nodes and modulates T lymphocyte subsets 176
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a) 174
Recombinant apolipoprotein A-IMilano: a novel agent for the induction of regression of atherosclerotic plaques 172
HDL therapy for the treatment of cardiovascular diseases 172
Hepatocyte-specific PPAP2B ablation increases plasma levels of several minor pro-atherogenic lipid species and worsens atherosclerosis in apoE(-/-) MICE 171
Activity profile of gemfibrozil on the major plasma lipoprotein parameters 170
Evaluation of nutritional and biological properties of a lupin protein isolate in sprague-dawley rats 168
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice : a clue to the disputed activity of statins on HDL 167
Impaired secretion of two apolipoprotein A-I mutants associated with hereditary amyloidosis 166
Rupatadine treatment is associated to atherosclerosis worsening and altered T lymphocytes 166
Hypolipidemic effect of dietary legume proteins: impact on genes regulating hepatic lipid metabolism 165
Acute effects of high-density lipoproteins : biochemical basis and clinical findings 163
Lack of transcriptional effects on apoA-I by Rosuvastatin in a transgenic mouse model 163
Evaluation of nutritional and biological properties of a lupin protein isolate in Sprague-Dawley rats 161
Skin morphology in double apoA-I/apoE knock-out mice : a structural and ultrastructural study 161
Sympathetic neurotransmission during atherosclerosis development: an unrecognized target of dyslipidemia? 161
Hypolipidemic effect of dietary pea proteins : impact on genes regulating hepatic lipid metabolism 160
Mechanisms of high-density lipoprotein reduction after probucol treatment: Changes in plasma cholesterol esterification/transfer and lipase-activities 160
Reference maps of mouse serum acute-phase proteins : changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes 159
Gene-expression profiling of lymph nodes reveals that apoa-i deficiency in apoe-ko mice induces a dramatic activation of the immune response 159
HDL and immune cell response : role of HDL on monocytes in humans and animal models 158
Effect of high cholesterol diet on cholesterol and bile acid metabolism in A-IM and A-I knock-in mice 157
The low plasma concentration of amyloidogenic apolipoprotein A-I can be explained by a reduced efficiencyof its cellular secretion 157
Alterata deposizione di lipidi e aumentato stato infiammatorio in topi normocolesterolemici con deficit di HDL 157
Topiramate protects ApoE-deficient mice from kidney damage without affecting plasma lipids 155
Increased cholesterol efflux potential of sera from ApoA-I-Milano carriers and transgenic mice 154
Lupin (Lupinus albus) protein isolate (L-ISO) has adequate nutritional value and reduces large intestinal weight in rats after restricted and ad libitum feeding 153
Anti-atherosclerotic activity of bioactive components from Antarctic krill in apoE-deficient mice 153
Sympathetic neurotransmission during atherosclerosis development: an unrecognized target of dyslipidemia? 153
ApoA-I expression stimulates blood fibrinolytic activity in transgenic mice 152
Gene expression profile reveals that APOA-I levels modulate inflammation and lysosomal activity in murine advances atherosclerosis 152
Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer 149
Dietary supplementation with tetradecylthioacetic acid or salmon peptides reduces atherosclerosis progression in apoE-KO mice 149
Impact of different dietary treatments on the molecular lipid profile of aortic plaques in apolipoprotein e-null mice : an example of lipidomics potential for translational medicine 149
Totale 23.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021231 0 0 0 0 0 0 0 0 0 0 0 231
2021/20224.188 231 202 214 408 273 427 339 327 509 499 279 480
2022/20233.026 375 225 303 283 316 603 70 189 310 58 217 77
2023/20242.715 99 186 241 292 595 176 125 119 88 253 233 308
2024/20255.493 201 522 127 548 475 281 288 624 286 439 486 1.216
2025/202611.882 1.037 589 1.100 843 964 735 1.524 700 1.379 1.004 1.238 769
Totale 38.636